At present, the importance of the pharmaceutical sector of the economy has increased significantly in public perception. This review provides up-to-date information at the beginning of 2022 on the main trends in the global pharmaceutical market. Among the current trends are: the key role of pharmaceuticals in the fight against the SARS-Covid-19 pandemic, the problems of a latent pandemic of drug-resistant infections, the high cost of new drugs and an increase in the market share of cheap biosimilars, the expansion of cooperation between developers of new drugs and vaccines, features in changes in the structure pharmaceutical companies, expanding opportunities in the retail pharmaceutical market, analysts? opinions on market prospects for the next 5 years. Materials from open sources were used: industry and business media, websites of pharmaceutical companies and non-profit organizations, WHO publications and scientific publications.
N. B. Dremova – Doctor of Pharmaceutical Sciences, Professor, Head of the Department of Pedagogy, Kursk State Medical University, Head of the Scientific School “Theory and Practice of Marketing Research in Pharmacy”, Kursk, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
S. V. Solomka – PhD in Pharmacy, Independent Researcher, Moscow, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it..
1. Ponomareva EV. TRENDWATCHING. Kak nayti idei dlya sozdaniya i razvitiya biznesa. Moscow: Litres; 2021. (In Russ). ISBN 9785042232121. Available at: https://www.litres.ru/elena-vasilevna-pono/trendwatching-kak-nayti-idei-dlya-sozdaniya-i-razviti/ (Accessed: 10 Feb 2022).
2. COVAX Announces new agreement, plans for first deliveries: News release. Geneva: WHO. 22 Jan 2021. Available at: https://www.who.int/news/item/22-01-2021-covax-announces-new-agreement-plans-for-first-deliveries (Accessed: 10 Sep 2021).
3. Evaluate Pharma World Preview 2021. Outlook to 2026 report. 14th ed. London: Evaluate Ltd., 2021. Available at: https://www.evaluate.com/thought-leadership/pharma/evaluate-pharma-world-preview-2021-outlook-2026 (Accessed: 10 Sep 2021).
4. Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medi-cine, for the Treatment of COVID-19 in Adults: News release by Merck. 25 Oct 2021. Available at: https://www.merck.com/news/merck-and-ridgeback-announce-initiation-of-a-rolling-review-by-the-european-medicines-agency-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-covid-19-in-adults/ (Accessed: 25 Oct 2021).
5. Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treat-ment: Press Release Pfizer. 22 Dec 2021. Available at: https://investors.pfizer.com/Investors/News/news-details/ 2021/Pfizer-Receives-U.S.-FDA-Emergency-Use-Authori-zation-for-Novel-COVID-19-Oral-Antiviral-Treatment/default.aspx (Accessed: 25 Dec 2021).
6. The Medicines Patent Pool (MPP) and MSD enter into licence agreement for molnupiravir, an investigational oral antiviral COVID-19 medicine, to increase broad access in low- and middle- income countries: Press Release MPP. 27 Oct 2021. Available at: https://medicinespatentpool.org/news-publications-post/mpp-msd-new-licence-announce-ment-molnupiravir/ (Accessed: 28 Oct 2021).
7. Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treat-ment Candidate to Expand Access in Low- and Middle-Income Countries: Press Release MPP. 16 Nov 2021. Available at: https://medicinespatentpool.org/news-publi-cations-post/pfizer-and-the-medicines-patent-pool-mpp-sign-licensing-agreement-for-covid-19-oral-antiviral-treatment-candidate-to-expand-access-in-low-and-middle-income-countries (Accessed: 18 Nov 2021).
8. Antimicrobial resistance: Fact sheets. Geneva: WHO. 17 Nov 2021: Available at: https://www.who. int/news-room/fact-sheets/detail/antimicrobial-resistance (Accessed: 31 Jan 2022).
9. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a sys-tematic analysis [published online ahead of print, Jan 18, 2022]. Lancet. 2022. Vol. 399, N10325 (Feb 12, 2022). P. 629-655. DOI: 10.1016/S0140-6736(21)02724-0.
10. Lack of new antibiotics threatens global efforts to contain drug-resistant infections: News release. Geneva: WHO. 17 Jan 2020. Available at: https://www.who.int/ru/news/item/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections (Accessed: 10 Sep 2021).
11. Website of the antimicrobial resistance action Fund (AMR Action Fund). Available at: https://www. amractionfund.com/about-us (Accessed: 28 Oct 2021).
12. Ribeiro da Cunha B, Fonseca LP, Calado CRC. Antibiotic Discovery: Where Have We Come from, Where Do We Go? Antibiotics. 2019;8(2):45. doi: 10.3390/antibi-otics8020045
13. Payne JAE, Tailhades J, Ellett F, et al. Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus. Nature Communications. 2021;12:6157. doi: 10.1038/s41467-021-26244-5
14. Sanofi to focus its COVID-19 development ef-forts on the recombinant vaccine candidate: Press Release Sanofi. 28 Sept 2021. Available at: https://www.sanofi. com/en/media-room/press-releases/2021/2021-09-28-18-44-47-2304800# (Accessed: 06 Nov 2021).
15. Pfizer and BioNTech Sign New Global Collabora-tion Agreement to Develop First mRNA-based Shingles Vaccine: Press Release Pfizer. 05 Jan 2022. Available at: https://investors.pfizer.com/Investors/News/news-details/2022/Pfizer-and-BioNTech-Sign-New-Global-Collaboration-Agreement-to-Develop-First-mRNA-based-Shingles-Vaccine/ default.aspx (Accessed: 25 Jan 2022).
16. IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology: Press Release IAVI and Moderna. 27 Jan 2022. Available at: https://www.iavi.org/news-resources/press-releases/2022/iavi-and-moderna-launch-trial-of-mrna-hiv-vaccine-antigens (Accessed: 31 Jan 2022).
17. Johnson & Johnson Announces Plans to Acceler-ate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business: Press Release Johnson&Johnson. 12 Nov 2021. Available at: https://www.jnj.com/johnson-johnson-announ-ces-plans-to-accelerate-innovation-serve-patients-and-consu-mers-and-unlock-value-through-intent-to-separate-consumer- health-business (Accessed: 25 Jan 2022).
18. Internet site AmazonPharmacy. Available at: https://pharmacy.amazon.com/how-it-works (Accessed: 31.01.2022).
19. Internet site Walmart. Available at: https://www. walmart.com/cp/pharmacy/5431 (Accessed: 31 Jan 2022).
20. Walgreens Boots Alliance Announces Transfor-mational Consumer-Centric Healthcare Strategy to Fuel Long-Term Growth: Press Release WBA. 14 Oct 2021. Available at: https://www.walgreensbootsalliance.com/news-media/press-releases/2021/walgreens-boots-alliance-announces-transformational-consumer-centric (Accessed: 31 Jan 2022).
21. Walgreens Boots Alliance Makes $5.2 Billion In-vestment in VillageMD to Deliver Value-Based Primary Care to Communities Across America: Press Release WBA. 14 Oct 2021. Available at: https://www.walgreens-bootsalliance.com/news-media/press-releases/2021/walgreens-boots-alliance-makes-52-billion-investment-villagemd (Accessed: 31 Jan 2022).
22. Internet site. Available at: https://www.cvs.com/ (Accessed: 31 Jan 2022).
23. CVS says sales will accelerate as it offers more health-care services, builds on pandemic gains. Available at: https://www.cnbc.com/2021/12/09/cvs-says-it-expects-earnings-revenue-to-grow-in-2022-as-it-steps-up-health-care-focus.html (Accessed: 31 Jan 2022).
24. Internet site LloydsPharmacy. Available at: https:// lloydspharmacy.com/ (Accessed: 31 Jan 2022).
25. Internet site LloydPharmacy Clinical Homecare. Available at: https://lpclinicalhomecare.co.uk/ (Accessed: 31 Jan 2022).
26. Internet site ПАО Сбербанк для акционеров и инвесторов. Available at: https://www.sberbank.com/ru/ eco/eapteka (Accessed: 31 Jan 2022).
27. Internet site СБЕР ЗДОРОВЬЕ. Available at: https://sberhealth.ru/ (Accessed: 31 Jan 2022).
The article can be purchased
electronic!
PDF format
Free
DOI 10.14489/lcmp.2022.01.pp.056-068
Article type:
Review
Make a request
